000 01632 a2200505 4500
005 20250515132058.0
264 0 _c20081003
008 200810s 0 0 eng d
022 _a1471-2164
024 7 _a10.1186/1471-2164-9-379
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBaumbusch, L O
245 0 0 _aComparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors.
_h[electronic resource]
260 _bBMC genomics
_cAug 2008
300 _a379 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Validation Study
650 0 4 _aAlgorithms
650 0 4 _aBreast Neoplasms
_xgenetics
650 0 4 _aChromosome Aberrations
650 0 4 _aCluster Analysis
650 0 4 _aDatabases, Genetic
650 0 4 _aFemale
650 0 4 _aGene Dosage
650 0 4 _aGene Expression Profiling
650 0 4 _aGenome, Human
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aOligonucleotide Array Sequence Analysis
_xmethods
650 0 4 _aOligonucleotide Probes
650 0 4 _aROC Curve
650 0 4 _aSensitivity and Specificity
700 1 _aAarøe, J
700 1 _aJohansen, F E
700 1 _aHicks, J
700 1 _aSun, H
700 1 _aBruhn, L
700 1 _aGunderson, K
700 1 _aNaume, B
700 1 _aKristensen, V N
700 1 _aLiestøl, K
700 1 _aBørresen-Dale, A-L
700 1 _aLingjaerde, O C
773 0 _tBMC genomics
_gvol. 9
_gp. 379
856 4 0 _uhttps://doi.org/10.1186/1471-2164-9-379
_zAvailable from publisher's website
999 _c18165660
_d18165660